The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...

AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...

Cherry, a full-service creative healthcare agency, has appointed Peter Henshaw as Managing Director. Henshaw will be ...

Exonate has appointed Olav Hellebø as Chief Executive Officer (CEO). Hellebø brings extensive business and scientific ...

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a deal worth around $10.0bn. Crinetics is a global ...

Alignment is not proven by whether teams are coordinated, it is proven by whether their combined efforts are sustained ...

Boehringer Ingelheim’s Jascayd (nerandomilast) tablets have been granted marketing authorisation by the Medicines and ...

The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates ...

In the emerging framework, a medicine’s value will increasingly depend on how effectively care is delivered around it’ ...

Ipsen is set to acquire Memo Therapeutics in a deal worth more than €700m EUR that is focused on potravitug, a phase 2 ...

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful ...

Launching prescription medicines excellently – achieving optimal commercial performance that reflects a medicine’s value and ...